User name:


Tianyuan Bio Pharma has gained an approval for a Phase III clinical trial of its
Group A ,Group A+C+Y+W135 Meningococcal polysaccharide vaccine.
  2 (6/2005)
 3 Henan Province's Symposia on the Prevention and Treatment of Influenza was held in Hangzhou (9/2004)


Copyright © 2003, Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd. All Rights Reserved.
Member of   
CPN   Supported by Hi2000